Related Experiment Video
Updated: Jun 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Multidisciplinary management of Hunter syndrome.
Joseph Muenzer1, M Beck, C M Eng
1Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina 27599-7487, USA. muenzer@med.unc.edu
Hunter syndrome, a rare X-linked disorder, results from iduronate-2-sulfatase deficiency, leading to GAG accumulation and multisystem disease. Management requires a multidisciplinary approach and enzyme-replacement therapy.
Area of Science:
- Biochemistry
- Genetics
- Rare Diseases
Background:
- Hunter syndrome is a rare, X-linked lysosomal storage disorder.
- It is caused by a deficiency in the enzyme iduronate-2-sulfatase.
- This deficiency leads to the accumulation of glycosaminoglycans (GAGs) in lysosomes, causing progressive, multisystem pathologies.
Purpose of the Study:
- To review the complex management of Hunter syndrome.
- To highlight the multidisciplinary approach required for patient care.
- To present enzyme-replacement therapy (ERT) as a specific treatment option.
Main Methods:
- Literature review of Hunter syndrome management strategies.
- Discussion of clinical manifestations across various organ systems.
- Overview of therapeutic interventions, including ERT.
Main Results:
- Hunter syndrome affects multiple systems including nervous, cardiovascular, respiratory, and musculoskeletal.
- Effective management necessitates a coordinated effort from various subspecialties.
- Enzyme-replacement therapy with recombinant human iduronate-2-sulfatase is a key therapeutic development.
Conclusions:
- Hunter syndrome requires specialized, multidisciplinary care due to its complex, progressive nature.
- Awareness of unique patient issues is crucial for effective management.
- Enzyme-replacement therapy offers a targeted treatment for this rare disorder.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Nephrotic Syndrome III : Nursing Management
Rheumatic Heart Disease III: Medical Management
Chronic Pancreatitis II: Collaborative Care
Assessment: